INGN Inogen, Inc. logo

INGN Inogen, Inc.

Healthcare
$6.40-0.16%ClosedMarket Cap: $173.3M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.96

P/S

0.49

EV/EBITDA

-18.59

DCF Value

$-6.53

FCF Yield

-5.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

48.7%

Operating Margin

-8.8%

Net Margin

-7.1%

ROE

-12.9%

ROA

-8.7%

ROIC

-13.2%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$85.1M$-8.3M$
Q4 null$81.7M$-7.1M$
FY null$348.7M$-22.7M$
Q3 null$92.4M$-5.3M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$26.00

Target (Median)

$26.00

Target Range

$26.00 - $26.00

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Richardson Jason Andrewofficer: EVP, CFO & Treasurer
SellWed Apr 08
Richardson Jason Andrew
SellWed Apr 08
Wright Mary Eofficer: VP, Chief Accounting Officer
SellTue Mar 03
Wright Mary Eofficer: VP, Chief Accounting Officer
SellTue Mar 03
Wright Mary Eofficer: VP, Chief Accounting Officer
SellTue Mar 03

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.65

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Peers